China is dropping an antitrust probe into Google, as Beijing and Washington step up trade negotiations over TikTok and Nvidia at a time of heightened tensions between the two countries, the Financial ... ...

Industry Overview - Biotech and healthcare stocks are responding positively to clinical trial progress, regulatory developments, and economic indicators, particularly with the Federal Reserve's first rate cut of 2025, which is expected to improve funding conditions for capital-intensive sectors like biotechnology [1] Company Highlights - **Sonnet BioTherapeutics Holdings Inc. (SONN)**: Shares increased by 11.19% in after-hours trading, reaching $7.85 after a regular session close of $7.06. The stock has a 52-week range of $1.08 - $19.30. The company expanded clinical evaluation of its lead candidate, SON-1010, for ovarian cancer, reporting a strong safety profile and a partial response at the highest dose level [2][3] - **Akari Therapeutics Plc (AKTX)**: Shares surged 11.58% in after-hours trading to $0.8855 after closing at $0.7936. The stock has a 52-week range of $0.5710 - $3.8500. The increase follows a provisional patent filing for its antibody-drug conjugate platform aimed at cancer treatment, which is expected to enhance its intellectual property and support the development of first-in-class ADCs [4][5] - **Safety Shot Inc. (SHOT)**: Shares rose 9.75% in after-hours trading to $0.3333 after closing at $0.3037. The company announced a strategic refresh of its Board of Directors with three new members to strengthen its capabilities in digital assets and operations [6][7] - **Reviva Pharmaceuticals Holdings Inc. (RVPH)**: Shares climbed 10.09% in after-hours trading to $0.4451 after closing at $0.4043. The stock has a 52-week range of $0.3000 - $4.2800. The price movement follows a revised analyst rating maintaining a "Speculative Buy" while lowering the price target from $14.00 to $7.00. Reviva's lead candidate, brilaroxazine, is being developed for multiple neuropsychiatric and respiratory indications [8][9][10] - **Cognition Therapeutics Inc. (CGTX)**: Shares rose 7.48% in after-hours trading to $1.58 after closing down at $1.47. The company is focused on its lead candidate, Zervimesine, for Alzheimer's disease, and recently closed a $30 million offering to support its Phase 3 development [12][13]

I am mostly a trader engaging in both long and short bets intraday and occasionally over the short- to medium term. My historical focus has been mostly on tech stocks but over the past couple of years I have also started broad coverage of the offshore drilling and supply industry as well as the shipping industry in general (tankers, containers, drybulk). In addition, I am having a close eye on the still nascent fuel cell industry.I am located in Germany and have worked quite some time as an auditor for Pric ...

Core Viewpoint - Panasonic is working on developing a new type of higher-capacity battery within approximately two years, which could significantly enhance the driving range of electric vehicles, marking a major advancement for the company as a supplier to Tesla [1] Company Summary - Panasonic aims to innovate in battery technology by creating a higher-capacity battery [1] - The development timeline for this new battery is set at around two years [1] Industry Summary - The advancement in battery technology is expected to have a substantial impact on the electric vehicle market, particularly in extending driving ranges [1] - As a key supplier to Tesla, Panasonic's innovations could influence competitive dynamics within the electric vehicle industry [1]

Core Viewpoint - Spirit Airlines is reducing its flight capacity by 25% as it navigates a second bankruptcy filing, aiming to optimize its network and focus on stronger markets [1][3][9] Company Actions - The airline will begin redesigning its flight network in November, leading to a year-over-year capacity reduction of approximately 25% [1] - CEO Dave Davis indicated that the restructuring will likely impact the workforce size, although specific details on layoffs were not provided [2][3] Financial Context - Spirit Airlines has filed for Chapter 11 bankruptcy twice within a year, with the first filing in November and the second in August [3][9] - The airline reported a revenue of $1.02 billion for the quarter ending in June, which represents a 20% decrease compared to the same period the previous year [8] Strategic Outlook - The company aims to execute a comprehensive restructuring to position itself for long-term success, which includes a potential reduction in flight routes and market presence [9]

India’s debate over how to handle cryptocurrencies has exposed a growing rift between two of its top financial regulators: the Securities and Exchange Board of India (SEBI) and the Reserve Bank of India (RBI). While SEBI has signaled openness to overseeing certain aspects of crypto trading, the RBI remains firmly opposed to granting legitimacy to digital assets, citing risks to financial stability. This divergence of views underscores the uncertainty that continues to define India’s stance on digital assets ...

Bullish Inc. BLSH CEO Tom Farley said Wednesday that the company’s flagship offerings, such as the CoinDesk 5 index, have the potential to become the “MSCI of the crypto world.”BLSH stock is showing exceptional strength. Get the inside scoop here.‘Bullish’ On Multi-Token IndicesDuring the company’s second-quarter earnings call, Farley responded to a query about Bullish’s indices business and plans to turn them into the “MSCI of the crypto world.”“People are looking for broader sets à la the Dow or the S&P 5 ...

The SEC just made a move that could speed up how crypto ETFs get approved in the United States. Until now, getting a spot crypto ETF listed was a long process, often dragging on for months. But with the new changes, exchanges like Nasdaq, NYSE, and Cboe can follow a standard rulebook instead of starting from scratch every time. In some cases, that could cut the wait from eight months down to about two and a half. What’s Actually Changing Before this update, each crypto ETF had to go through a double appr ...

Group 1 - Burberry is focusing on a turnaround strategy that emphasizes its British heritage and classic trench coats [1] - The company has enlisted high-profile figures such as Oscar winner Olivia Colman and Oasis frontman Liam Gallagher to promote its brand [1] - A significant test for this strategy will occur when Burberry unveils its latest designs at London Fashion Week [1]

Group 1: Morning Routine Investments - Discussion includes Keurig coffee and Crest toothpaste as everyday products [1] - Companies analyzed include Dr. Pepper and Keurig Dr Pepper [1][2] - Procter & Gamble highlighted as a household giant with significant market presence [2] Group 2: Healthcare and Automotive Investments - Johnson & Johnson recognized as a staple in the healthcare sector [1][2] - Automotive investments cover a range of manufacturers from Ferrari to Tesla [1][2] Group 3: Fast Food and Franchise Insights - McDonald's discussed as a breakfast investment opportunity [1] - Insights into the franchise model and its implications for revenue generation [1] - Domino's Pizza revenue analyzed, indicating growth potential [1][2] Group 4: Entertainment and Grocery Stocks - Spotify and Apple examined for their financial metrics and growth potential [2] - Grocery stores like Kroger and Sprouts compared for investment viability [2]